Showing results (361-370 of 538) with videos related to

Sort By:
Pageof 54
Inflammopharmacology|April 22, 2017
Immunomodulatory and therapeutic role of Cinnamomum verum extracts in collagen-induced arthritic BALB/c miceMirza Muhammad Fahd Qadir, Attya Bhatti, Muhammad Usman Ashraf, et al.
Plos One|June 18, 2021
EEG in game user analysis: A framework for expertise classification during gameplayTehmina Hafeez, Sanay Muhammad Umar Saeed, Aamir Arsalan, et al.
Brain : a Journal of Neurology|May 28, 2019
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J Goadsby, Linda A Wietecha, Ellen B Dennehy, et al.
Cephalalgia : an International Journal of Headache|January 20, 2017
Neck-Tongue syndrome: A systematic reviewAmy A Gelfand, Hannah Johnson, Marc Ep Lenaerts, et al.
Brain Research|May 25, 2005
Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the catYolande E Knight, John D Classey, Michele P Lasalandra, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
The New England Journal of Medicine|August 18, 2021
Atogepant for the Preventive Treatment of MigraineJessica Ailani, Richard B Lipton, Peter J Goadsby, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Neurobiology of Disease|December 3, 2014
Evidence for orexinergic mechanisms in migraineJan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Pageof 54